With a staggering 537 million adults already living with diabetes worldwide—a number set to soar to 783 million by 2045—this silent epidemic is exacting a devastating human and economic toll that demands our immediate attention.
Key Takeaways
- In 2021, approximately 537 million adults (aged 20-79 years) were living with diabetes worldwide, representing 10.5% of this age group
- By 2045, the global diabetes prevalence among adults aged 20-79 years is projected to reach 783 million, an increase of 46%
- In 2021, 46% of adults with diabetes worldwide (240 million people) were undiagnosed
- In 2021, diabetes caused 6.7 million deaths worldwide, equivalent to one death every 5 seconds
- Diabetes accounted for 12.2% of all deaths globally in adults aged 20-79 years in 2021
- In 2021, 3.4 million deaths from diabetes were in low- and middle-income countries
- The global economic burden of diabetes was estimated at USD 966 billion in 2021, representing 9.4% of total health expenditure
- Direct healthcare costs for diabetes worldwide reached USD 460 billion in 2021 for adults aged 20-79
- Indirect costs (lost productivity) from diabetes amounted to USD 506 billion globally in 2021
- Overweight and obesity contributed to 44% of the diabetes disease burden globally in 2021
- Physical inactivity accounts for 6.8% of diabetes cases worldwide
- 90% of type 2 diabetes cases are linked to modifiable lifestyle factors globally
- Only 11% of people with diabetes worldwide had access to insulin in low-income countries in 2021
- Globally, 49% of type 2 diabetes patients achieved HbA1c <7% target in 2021 surveys
- Blood glucose monitoring strips cost prohibitive for 80% in low-income settings
Global diabetes cases are rising rapidly and will impact nearly 800 million adults by 2045.
Economic Impact
- The global economic burden of diabetes was estimated at USD 966 billion in 2021, representing 9.4% of total health expenditure
- Direct healthcare costs for diabetes worldwide reached USD 460 billion in 2021 for adults aged 20-79
- Indirect costs (lost productivity) from diabetes amounted to USD 506 billion globally in 2021
- By 2045, total diabetes-related health expenditure is projected to reach USD 1 trillion worldwide
- In high-income countries, per capita diabetes health spending was USD 1,917 in 2021
- Low-income countries spent only USD 682 per person with diabetes on health in 2021
- USA diabetes costs totaled USD 412.9 billion in 2022, up from previous years
- Globally, 40% of diabetes expenditure in 2021 was on hospitalizations
- China’s diabetes economic burden was USD 102 billion in 2021
- In the EU, diabetes cost €129 billion annually around 2021
- Lost productivity from diabetes premature mortality was USD 251 billion globally in 2021
- India faced USD 64 billion in diabetes costs in 2021, projected to USD 106 billion by 2045
- In MENA region, diabetes expenditure was USD 18.3 billion in 2021
- Brazil's direct diabetes costs reached USD 3.5 billion in 2021
- Globally, insulin costs represent 11% of total diabetes expenditure in 2021
- Workplace absenteeism due to diabetes costs USD 27 billion annually worldwide circa 2021
- In 2021, Germany spent €28.3 billion on diabetes care
- Sub-Saharan Africa diabetes costs were USD 9 billion in 2021
Economic Impact Interpretation
The staggering global diabetes bill—nearing a trillion dollars and set to keep climbing—reveals a world where we're paying exorbitantly in both cash and human potential to treat a crisis we should be far smarter about preventing.
Mortality/Morbidity
- In 2021, diabetes caused 6.7 million deaths worldwide, equivalent to one death every 5 seconds
- Diabetes accounted for 12.2% of all deaths globally in adults aged 20-79 years in 2021
- In 2021, 3.4 million deaths from diabetes were in low- and middle-income countries
- Cardiovascular disease caused 24% of diabetes-related deaths in 2021 globally
- Globally, diabetes reduced life expectancy by 3 years on average in 2021 for those aged 20-79
- In 2021, kidney disease accounted for 11% of deaths among people with diabetes worldwide
- People with diabetes have a 2-3 times higher risk of heart attack or stroke compared to non-diabetics
- In 2021, 47% of diabetes-related deaths occurred before age 70 worldwide
- Diabetes complications led to 1.5 million disability-adjusted life years (DALYs) lost globally per million population in 2021
- In low-income countries, diabetes mortality rate was 92 per 100,000 in 2021
- Globally, 541,000 deaths from diabetes occurred in women aged 20-79 in 2021
- Chronic kidney disease prevalence among diabetics was 30-40% worldwide in 2021
- Diabetes retinopathy affects up to 80% of people with long-standing type 2 diabetes globally
- In 2021, foot ulcers affected 6.3% of diabetics worldwide, leading to 1 million leg amputations annually
- Neuropathy prevalence in diabetes patients reached 50% globally in recent studies
- Hospitalization rates for diabetes complications were 2.5 times higher in diabetics vs non-diabetics worldwide
- In 2021, diabetes contributed to 13% of total cardiovascular deaths globally
- Global years lived with disability (YLDs) due to diabetes increased by 28% from 1990 to 2021
- In Africa, diabetes mortality rate was projected to double by 2045 from 2021 levels
Mortality/Morbidity Interpretation
The grim clockwork of diabetes ticks with a ruthless, global rhythm, stealing a life every five seconds and chipping away at years, hearts, kidneys, and limbs from the wealthy nations to the most vulnerable, where its shadow grows longest and darkest.
Prevalence/Incidence
- In 2021, approximately 537 million adults (aged 20-79 years) were living with diabetes worldwide, representing 10.5% of this age group
- By 2045, the global diabetes prevalence among adults aged 20-79 years is projected to reach 783 million, an increase of 46%
- In 2021, 46% of adults with diabetes worldwide (240 million people) were undiagnosed
- The highest diabetes prevalence rates in 2021 were in the MENA region at 12.2% for adults aged 20-79 years
- Globally, diabetes prevalence among adults aged 20-79 years was higher in urban (10.8%) than rural (7.2%) areas in 2021
- In 2021, there were 24 million children and adolescents (0-19 years) living with diabetes worldwide
- The Western Pacific region had the largest number of adults with diabetes in 2021 at 206 million
- Diabetes incidence among adults aged 20-79 years is expected to increase by 17% globally from 2021 to 2045
- In low-income countries, diabetes prevalence rose from 3.6% in 1990 to 5.5% in 2021 among adults
- South-East Asia had 90 million adults with diabetes in 2021, projected to 151 million by 2045
- Globally, 1 in 9 adults aged 20-79 years (10.5%) had diabetes in 2021
- In 2021, Africa had the lowest diabetes prevalence at 4.5% but highest projected increase of 129% by 2045
- Women worldwide had a diabetes prevalence of 10.1% compared to 10.9% in men aged 20-79 in 2021
- The number of adults with diabetes in high-income countries was 123 million in 2021
- In 2021, 44 million adults aged 20-79 years in the United States had diabetes
- Global diabetes prevalence in adults aged 65+ was 17.5% in 2021
- Middle East and North Africa region saw diabetes cases rise from 20 million in 2000 to 73 million in 2021
- In 2021, 529 million adults lived with diabetes globally, with China having 140 million cases
- Europe had 61 million adults with diabetes in 2021, prevalence 6.9%
- Global age-standardized diabetes prevalence increased from 4.7% in 1980 to 6.1% in 2021
Prevalence/Incidence Interpretation
We are losing the global race between our health and our habits, with nearly half the competitors unknowingly running blindfolded toward a finish line where one in ten of us is already diabetic and the crowd of 783 million waiting in 2045 looks worryingly like a grim victory parade.
Risk Factors/Causes
- Overweight and obesity contributed to 44% of the diabetes disease burden globally in 2021
- Physical inactivity accounts for 6.8% of diabetes cases worldwide
- 90% of type 2 diabetes cases are linked to modifiable lifestyle factors globally
- Smoking increases type 2 diabetes risk by 30-40% according to global meta-analyses
- Gestational diabetes affects 14% of pregnancies worldwide, raising future type 2 risk
- Family history doubles the risk of type 2 diabetes globally
- High blood pressure is present in 50% of people with type 2 diabetes worldwide
- Polycystic ovary syndrome (PCOS) increases diabetes risk 3-7 fold in women globally
- Age over 45 years raises diabetes risk significantly, with prevalence doubling every decade
- South Asians have 2-4 times higher diabetes risk at lower BMI levels than Europeans
- Excessive alcohol consumption increases diabetes risk by 43% per global studies
- Poor sleep (less than 6 hours/night) raises diabetes risk by 28% worldwide
- Air pollution exposure linked to 10-20% increased diabetes incidence in urban areas globally
- Low birth weight infants have 2-fold higher risk of type 2 diabetes in adulthood
- Shift work disrupts circadian rhythms, increasing diabetes risk by 9% per meta-analysis
- Depression is associated with 60% higher diabetes risk globally
- Chronic stress elevates cortisol, contributing to 20-30% higher diabetes incidence
- High fructose corn syrup consumption correlates with rising diabetes rates in 40 countries
- Vitamin D deficiency linked to 43% increased diabetes risk in global cohorts
- Sedentary behavior (over 10 hours/day) raises risk by 112% according to WHO data
Risk Factors/Causes Interpretation
If humanity held a referendum on type 2 diabetes, the overwhelming vote would be for a platform of modern living—where our chairs, screens, stress, and snacks are the primary campaigners, and genetics is merely the unfortunate running mate.
Treatment/Management
- Only 11% of people with diabetes worldwide had access to insulin in low-income countries in 2021
- Globally, 49% of type 2 diabetes patients achieved HbA1c <7% target in 2021 surveys
- Blood glucose monitoring strips cost prohibitive for 80% in low-income settings
- Metformin is used by 80% of type 2 diabetes patients as first-line therapy worldwide
- Continuous glucose monitoring (CGM) adoption was under 1% globally outside high-income countries in 2021
- Statins prescribed to only 40% of diabetics despite CVD risk guidelines worldwide
- Diabetes self-management education reaches less than 50% of patients globally
- GLP-1 receptor agonists used by 5% of type 2 patients in Europe, lower elsewhere in 2021
- Foot care screening performed in only 20-30% of diabetes clinics worldwide annually
- Retinopathy screening coverage was 60% in high-income vs 10% in low-income countries in 2021
- Bariatric surgery recommended for BMI>35 with diabetes, but access <1% globally
- ACE inhibitors for nephropathy in 50% of eligible diabetics worldwide circa 2021
- Lifestyle interventions reduce diabetes incidence by 58% in high-risk groups per DPP study global adaptations
- SGLT2 inhibitors adopted by 10% of type 2 patients in 2021, mainly high-income
- Aspirin prophylaxis in 30% of high-risk diabetics globally despite guidelines
Treatment/Management Interpretation
The global diabetes care landscape is a tale of two worlds: a frustrating farce where we possess nearly all the effective tools yet choose, through neglect and inequity, to let most patients fight a losing battle with a half-empty toolbox.
Sources & References
- Reference 1DIABETESATLASdiabetesatlas.orgVisit source
- Reference 2IDFidf.orgVisit source
- Reference 3WHOwho.intVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5NCBIncbi.nlm.nih.govVisit source
- Reference 6THELANCETthelancet.comVisit source
- Reference 7KIDNEYkidney.orgVisit source
- Reference 8NEInei.nih.govVisit source
- Reference 9OECDoecd.orgVisit source
- Reference 10AHAJOURNALSahajournals.orgVisit source
- Reference 11DIABETESdiabetes.orgVisit source
- Reference 12ECec.europa.euVisit source
- Reference 13NIDDKniddk.nih.govVisit source
- Reference 14DIABETESJOURNALSdiabetesjournals.orgVisit source
- Reference 15NEJMnejm.orgVisit source